arked reductions in cardiovascular mortality in women have occurred for the first time this decade as a result of advances in medical treatment, improvement in medical technology, and a greater focus on women and their cardiovascular risk. 1 Nonetheless, cardiovascular disease remains the No. 1 cause of death for women in the United States, and more women die from cardiovascular disease than men every year. 2 In addition, women with coronary artery disease (CAD) are more likely to have a poorer prognosis than men. 1, 3, 4 Women who have an acute myocardial infarction have a higher mortality than their male counterparts, and women who have symptoms of angina or an abnormal stress test are less likely to be referred for further diagnostic testing. 2, [5] [6] [7] Given these gender differences in the evaluation of possible CAD symptoms and the higher mortality due to CAD in women, critical steps should be taken to identify women at the earliest stage of presentation so that appropriate therapeutic strategies can be implemented. Nonetheless, identifying women with coronary disease can be a diagnostic challenge. The prevalence of CAD in younger women is low, and women tend to present with symptoms and CAD at older ages as compared with men. In addition, women may present with more atypical symptoms. 8 Women also have a lower prevalence of obstructive coronary disease, making diagnostic testing designed to detect focal areas of coronary stenosis less sensitive and specific in this population. 9 Currently, exercise stress testing is the most commonly used method of diagnosing CAD in women, 10 -12 Historically, exercise stress testing in women has been thought to have a decreased diagnostic accuracy because of a lower prevalence of CAD in women, but most early studies evaluating stress testing as a diagnostic tool were performed in almost exclusively male cohorts. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Until recently, the representation of women in published studies was too small to determine any gender differences in test accuracy. The underrepresentation of women, as well as the bias in selection of women when included, may be the reason for the misconceptions regarding the value of exercise stress testing in women. Nonetheless, research on exercise stress testing in women has increased in the past decade, improving our understanding of the diagnostic and prognostic value of this modality in women.
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arked reductions in cardiovascular mortality in women have occurred for the first time this decade as a result of advances in medical treatment, improvement in medical technology, and a greater focus on women and their cardiovascular risk. 1 Nonetheless, cardiovascular disease remains the No. 1 cause of death for women in the United States, and more women die from cardiovascular disease than men every year. 2 In addition, women with coronary artery disease (CAD) are more likely to have a poorer prognosis than men. 1, 3, 4 Women who have an acute myocardial infarction have a higher mortality than their male counterparts, and women who have symptoms of angina or an abnormal stress test are less likely to be referred for further diagnostic testing. 2, [5] [6] [7] Given these gender differences in the evaluation of possible CAD symptoms and the higher mortality due to CAD in women, critical steps should be taken to identify women at the earliest stage of presentation so that appropriate therapeutic strategies can be implemented. Nonetheless, identifying women with coronary disease can be a diagnostic challenge. The prevalence of CAD in younger women is low, and women tend to present with symptoms and CAD at older ages as compared with men. In addition, women may present with more atypical symptoms. 8 Women also have a lower prevalence of obstructive coronary disease, making diagnostic testing designed to detect focal areas of coronary stenosis less sensitive and specific in this population. 9 Currently, exercise stress testing is the most commonly used method of diagnosing CAD in women, 10 -12 and the exercise stress ECG is the initial noninvasive study of choice in the diagnosis of CAD. Both the 2002 American Heart Association/American College of Cardiology (AHA/ACC) Guidelines for Exercise Testing 13 and the 2005 Guidelines for the Role of Noninvasive Testing in the Clinical Evaluation of Women with Suspected Coronary Artery Disease 14 recommend the exercise ECG as the first diagnostic test of choice in symptomatic, intermediate-risk women with a normal baseline ECG. Historically, exercise stress testing in women has been thought to have a decreased diagnostic accuracy because of a lower prevalence of CAD in women, but most early studies evaluating stress testing as a diagnostic tool were performed in almost exclusively male cohorts. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Until recently, the representation of women in published studies was too small to determine any gender differences in test accuracy. The underrepresentation of women, as well as the bias in selection of women when included, may be the reason for the misconceptions regarding the value of exercise stress testing in women. Nonetheless, research on exercise stress testing in women has increased in the past decade, improving our understanding of the diagnostic and prognostic value of this modality in women.
The purpose of this article is to review the literature regarding exercise stress testing in women, with a focus beyond ST-segment depression alone. It addition to interpretation of ECG changes with exercise, evaluation of exercise capacity, chronotropic index, heart rate (HR) recovery (HRR), blood pressure response, and Duke Treadmill Score (DTS) can be used to enhance the utility of exercise testing. The diagnostic and prognostic value of these non-ECG variables in women is reviewed, with a goal of highlighting the importance of exercise stress testing in women on the basis of the research available to date.
ST-Segment Depression

Diagnostic Value
ST-segment depression that occurs with exercise stress testing reflects ischemia, which may indicate the presence of obstructive CAD. ST-segment depression that occurs with exercise stress testing is thought to be less accurate in identifying CAD in women than in men. 26 The sensitivity and specificity of ST-segment depression with an exercise ECG in symptomatic women vary widely depending on the study, with the sensitivity generally being worse than the specificity. The sensitivity and specificity for the diagnosis of CAD in women range from 31% to 71% and 66% to 86%, respectively. 21, [27] [28] [29] [30] [31] [32] [33] In a meta-analysis of exercise testing in women, the sensitivity and specificity for ST-segment depression in symptomatic, intermediate-risk women were 61% and 70%, respectively. 27 This is compared with a sensitivity and specificity of 68% and 77%, respectively, in a meta-analysis of predominantly male participants. 34 In a study of symptomatic men and women undergoing exercise ECG and subsequent angiography, the positive predictive value of ST-segment depression with exercise testing in women was significantly lower than in men (47% versus 77%, respectively; PϽ0.05). 35 However, the negative predictive value (NPV) of ST-segment depression in symptomatic women was similar to that of men (78% versus 81%, respectively). Although women are more likely to have a "false-positive" exercise ECG, a negative exercise stress test is useful in effectively ruling out a diagnosis of CAD.
Differences in the accuracy of ST-segment depression for men and women may be explained by several factors. First, women are more likely than men to have baseline ST-and T-wave changes, making interpretation of ECG changes with exercise difficult. 36, 37 Second, it has been thought that women have more ST-segment depression with exercise testing. 32 In an early study that included both asymptomatic men and women, women were more likely than men to have STsegment depression after 3 minutes of exercise (16% of women versus 3% of men). 38 However, in larger and more recent studies of asymptomatic women, ST-segment depression appears far less common than noted in prior reports. 39, 40 ST-segment depression with exercise stress testing occurred in 6.2% of the 5721 women in the St James Women Take Heart Project cohort 39 and in 4.7% of the 2994 women in the Lipid Research Clinics study. 40 Third, it has been hypothesized that estrogen (natural or otherwise) may cause a digoxin-like effect on ST segments with exercise, which may account for the difference in accuracy in ST-segment depression in women compared with men. In premenopausal women with no CAD, the presence of ST-segment depression during exercise appears to vary with the menstrual cycle. 41 Furthermore, postmenopausal women receiving oral estrogen therapy are more likely to have exercise-induced ST-segment depression with normal coronary angiograms than postmenopausal women not on estrogen replacement. 42 Finally, women are generally older when they present for stress testing and may have a decreased exercise tolerance, decreasing the ability of the test to induce ischemia and ST-segment depression and limiting the ability to accurately identify women with CAD. 14 
Prognostic Value
Although ST-segment depression with exercise provides some diagnostic information in women, these same ECG changes do not appear to provide strong prognostic value in women. In the large cohort of Ͼ5000 asymptomatic women from the St James Women Take Heart Project, there was no relationship between ST-segment depression with exercise stress testing and cardiovascular mortality or all-cause mortality. 39, 43 The frequency of ST-segment depression was the same in women who died and those who survived (6.2% versus 6.4%; Pϭ0.99). A similar relationship between STsegment depression with exercise testing and cardiovascular and all-cause mortality was described among the asymptomatic women from the Lipid Research Clinics, 40 in contrast to the relationship seen between ST-segment depression with exercise testing and cardiovascular and all-cause mortality in asymptomatic men. 44 
Exercise Capacity
Exercise capacity, also known as functional capacity or cardiorespiratory fitness, has emerged as one of the most important diagnostic and prognostic markers that can be easily assessed with exercise stress testing. 24, [45] [46] [47] [48] [49] Exercise capacity is an estimate of the maximal oxygen uptake for a given workload and can be expressed in metabolic equivalents (METs). 50 One MET is a unit of basal oxygen consumption, which equals 3.5 mL of oxygen consumption per kilogram of body weight per minute for an average adult. The exercise capacity can be estimated for any exercise stress protocol with the use of the speed and grade of the treadmill at peak exercise or the workload achieved on a bicycle ergometer. 51 
Diagnostic Value
Exercise capacity has been shown to be an independent predictor of the presence of CAD in women. In a study of 135 symptomatic women undergoing exercise stress testing and subsequent angiography, maximal exercise capacity achieved was among the best stress testing variables for predicting the presence of CAD and improved the sensitivity and specificity of exercise stress testing when added to ST-segment depression. 49 This finding was confirmed in a group of 419 women and 555 men who underwent maximal exercise stress testing for symptom evaluation with the use of the Bruce protocol with single photon emission computed tomography (SPECT) imaging. Those who achieved Ն10 METs had a very low prevalence of significant ischemia (defined as Ն10% of the left ventricle on myocardial perfusion imaging), but those who achieved Ͻ7 METs were more likely to have significant ischemia (0.4% versus 7.1%; PϽ0.001). 52 No (0%) significant ischemia was observed in participants who achieved Ͼ10 METs and had no ST-segment depression with exercise.
Prognostic Value
Exercise capacity has strong prognostic implications in asymptomatic and symptomatic women. 39, 40, [53] [54] [55] In a retrospective study of exercise stress testing in a symptomatic referral population that included 741 women, exercise capacity was the only exercise stress testing variable that was an independent predictor of mortality. 53 For every 1-MET increase in exercise capacity, there was a 25% reduction in risk of all-cause mortality and a 23% reduction in risk of cardiac events for women. 53 Exercise capacity has also been shown to be a strong independent predictor of all-cause mortality in asymptomatic women, beyond traditional cardiac risk factors. 39, 40, 56 In the St James Women Take Heart Project, those asymptomatic women who were unable to achieve 5 METs on a Bruce protocol had a 3-fold increased risk of death compared with women who achieved Ͼ8 METs. 39 For each additional MET achieved on the exercise stress test, there was a 17% reduction in mortality, after controlling for traditional cardiac risk factors. These results were confirmed in the asymptomatic women from the Lipid Research Clinics study as well. 40 In addition to absolute exercise capacity achieved, agepredicted exercise capacity can be determined after exercise stress testing and used for prognosis in women. Agepredicted exercise capacity was defined with the use of the large cohort of asymptomatic women from the St James Women Take Heart Project, 57 who underwent a symptomlimited, maximal stress test with the use of the Bruce protocol. There was a linear and inverse relationship between age and exercise capacity. On the basis of the linear regression analysis of exercise capacity for age, the following equation was developed 57 :
Predicted METsϭ14.7Ϫ͑0.13ϫage͒
A nomogram was constructed for simplicity of use of this calculation, in which age and achieved fitness level can be used to determine a woman's percentage of age-predicted fitness level achieved ( Figure 1 ). 57 This relationship between age and exercise capacity and the ability to achieve a woman's age-predicted fitness level was shown to be a predictor of both all-cause and cardiovascular mortality in asymptomatic women. Compared with asymptomatic women who achieved Ն85% of their age-predicted exercise capacity, those who achieved an exercise capacity Ͻ85% of their age-predicted value had approximately twice the risk of death from any cause (hazard ratioϭ2.0; PϽ0.001) and a slightly greater risk of death from cardiac causes (hazard ratioϭ2.4; PϽ0.001).
Furthermore, age-predicted exercise capacity for women was validated as a prognostic indicator in 4421 symptomatic women from the Economics of Noninvasive Diagnosis (END) study. These women also underwent a symptomlimited exercise stress test with the use of the Bruce protocol and were followed for events. Those symptomatic women who achieved Ͻ85% of their age-predicted exercise capacity also had at least twice the risk of death from any cause and cardiac causes compared with women who achieved Ն85% of their age-predicted exercise capacity (hazard ratioϭ2.4; PϽ0.001, and hazard ratioϭ2.0; PϽ0.001, respectively). In this study, asymptomatic and symptomatic women whose observed exercise capacity exceeded their age-predicted exercise capacity by at least 3 METs had a lower risk of death from any cause than their less-fit counterparts. 57 
Chronotropic Response
The normal chronotropic response to exercise is based on the physiological requirement of the body to increase its cardiac output. This requires augmentation of both the HR and stroke volume. However, after the HR increases to Ͼ110 to 120 bpm, stroke volume ceases to increase, at which point HR alone contributes to the increase in cardiac output. 58 The peak HR achieved with maximal exercise testing is influenced by both age and gender. 59, 60 An attenuated HR response to exercise (or an abnormal chronotropic response) is defined as chronotropic incompetence 21, 61 and has been associated with poorer prognosis. 60, [62] [63] [64] Measures of chronotropic response include the following: (1) peak HR achieved with maximal exercise stress testing; (2) HR reserve or change in HR with exercise (peak HR with exercise minus resting HR); (3) ability to achieve at least 85% of the maximum age-predicted HR; and (4) chronotropic index. The latter 2 parameters have been the most studied in women.
Ability to Reach 85% of Maximum Age-Predicted HR
In the diagnosis of CAD, the ability to reach 85% of the maximum age-predicted HR with exercise can be used to determine the likelihood of CAD. In a small study of 200 symptomatic women undergoing exercise testing, inability to reach target HR was associated with higher likelihood of CAD. 65 The ability to reach target HR also has prognostic value in women. Lauer et al 63 demonstrated that the inability to achieve 85% of maximum age-predicted HR (defined as 220Ϫage) was associated with decreased survival in both men and women. More recently, on the basis of the St James Women Take Heart cohort, the peak HR for age in women was redefined as 206Ϫ0.88(age). 60 In this cohort of women, for every 1-bpm increase in peak HR with exercise achieved, there was a 3% reduction in all-cause mortality (PϽ0.001), and for every 1-bpm increase in HRR, there was 2% reduction in mortality (PϽ0.001), after controlling for traditional cardiac risk factors and exercise capacity. The inability to achieve 85% of age-predicted HR (with the use of the traditional estimate for age or the new equation for women) was not an independent predictor of mortality in these asymptomatic women. This new equation has not been validated, as of yet, in a symptomatic cohort of women.
Despite its possible diagnostic value, achievement of 85% of age-predicted HR was never intended to be an end point of any stress test protocol, 13, 66 and terminating exercise before symptoms occur may result in an inadequate exercise stress test. 39, 40, 56 
Chronotropic Index
Chronotropic index, defined as the ratio between HRR and metabolic reserve, is another measure of chronotropic response that has substantial prognostic value. 64, 67 In a healthy subject, HRR and metabolic reserve are equal, and therefore a normal chronotropic index should be Ϸ1.0. An abnormal chronotropic index is defined as Ͻ0.80. Chronotropic index can account for differences in baseline resting HR and functional capacity. 64 In a cohort of symptomatic women and men referred for exercise testing, a low chronotropic index (Ͻ0.80) was shown to be an independent predictor of mortality (hazard ratioϭ2.19; PϽ0.001). 63 Chronotropic index was also shown to be a superior measure compared with 57 the ability to achieve 85% of the maximum age-predicted HR in the prediction of cardiac death and all-cause mortality. 62 In the asymptomatic women from the St James Women Take Heart Project, when the chronotropic index was calculated, the newer estimate of peak HR for age in women was used. On the basis of the new value of age-predicted HR, chronotropic index was a better predictor of all-cause mortality compared with either the ability to achieve 85% of maximal age-predicted HR or the chronotropic index calculated with the use of the traditional age-predicted peak HR estimate (220Ϫage). A chronotropic index of Ͻ0.80 was associated with a 30% increase in mortality from any cause (PϽ0.023) in asymptomatic women, after adjustment for cardiac risk factors and exercise capacity. 60 
HR Recovery Prognostic Value
HRR, defined as peak HR achieved minus HR 1 minute into recovery, has been shown to have independent prognostic value in women as well as men. 68 -70 In a study that included 720 women who underwent exercise stress testing and subsequent angiography, 25% had an abnormal HRR (defined as a decrease in the HR of Ͻ12 bpm in the first minute of recovery). An abnormal HRR was found to be an independent predictor for all-cause mortality (hazard ratioϭ1.5; Pϭ0.0002). 70 This finding was confirmed in the asymptomatic women in the Lipid Research Clinics study, in which abnormal HRR was found to be an independent predictor of all-cause mortality and cardiovascular death. 40 
HR-Adjusted Measures of ST Depression:
⌬ST/⌬HR Index and ST/HR Slope
Diagnostic Value
HR-adjusted measures of ST-segment depression have been developed to improve the diagnostic accuracy of ST depression with exercise stress testing. One such measure is the ⌬ST/⌬HR index, which is HR-adjusted ST-segment depression. The ⌬ST/⌬HR index during exercise stress testing can increase the specificity (94%) and sensitivity (94%) of exercise testing in women, with greater test sensitivity in women compared with men. 67 The use of the ⌬ST/⌬HR index has been shown to improve the sensitivity to detect significant 3-vessel CAD by 33% to 35%. The ST/HR slope, or the rate of ST-segment depression with respect to increase in HR, has also been shown to increase the diagnostic value of the exercise ECG. 71 For women particularly, the use of the ST/HR slope may improve the sensitivity of the exercise ECG. 67 Despite the improved diagnostic accuracy of these measures, neither is used routinely in the interpretation of exercise stress testing in women. Some have argued that the ⌬ST/⌬HR index is statistically flawed because the respective weight given to both ST-segment depression and the change in HR response to exercise by the formula may be inaccurate. 72, 73 Because of the possible flaws in this technique and the technical difficulty in doing the calculation, neither are commonly used in clinical practice. 74 
Blood Pressure Response to Exercise
Exercise is associated with an increase in sympathetic tone and skeletal blood flow but a decrease in peripheral resistance. 75 With exercise, a rise in systolic blood pressure is expected (to a maximum of 230 mm Hg), whereas the change in diastolic blood pressure can vary (10-mm Hg increase or decrease). Abnormal changes in blood pressure response with exercise have both diagnostic and prognostic value.
Diagnostic Value
A hypotensive response to exercise, defined as a fall in systolic blood pressure Ͼ10 mm Hg, may reflect acute left ventricular dysfunction due to ischemia. Studies that include predominantly male participants suggest that this drop in systolic blood pressure with exercise may be a very specific marker of the presence of left main or severe triple-vessel CAD, 76 -78 particularly if ST-segment depression occurs as well. 78 However, the diagnostic value of a drop in systolic blood pressure with exercise in women is unclear. One study suggested that the specificity was lower in women because the hypotensive response appeared to occur more frequently in women in the absence of CAD, 79 but other studies were unable to demonstrate its occurrence in women with normal coronary angiograms. 78 
Prognostic Value
An abnormal rise in blood pressure with exercise stress testing and during recovery has been shown to be associated with an increased risk of developing hypertension in both women and men. 80, 81 In asymptomatic men and women undergoing exercise stress testing in the Coronary Artery Risk Development in Young Adults (CARDIA) study, participants who had an exaggerated blood pressure response (defined as Ն210 mm Hg in men or Ն190 mm Hg in women) were 1.7 times more likely to have hypertension at the 5-year follow-up visit compared with those with a normal blood pressure response. 80 The pattern of exaggerated blood pressure response between men and women may differ. In the Framingham Offspring Study, which included asymptomatic men (nϭ1026) and women (nϭ1284), an exaggerated diastolic blood pressure response with exercise was predictive of hypertension in both genders, but an elevated systolic blood pressure in recovery was only predictive of the development of hypertension in men. 81 
Duke Treadmill Score
Multiple risk scores have been developed that incorporate specific exercise stress testing and clinical variables, and they have been shown to be more useful than single variables in the diagnosis of CAD, in addition to improving the prognostic capabilities of exercise stress testing. 49, 82, 83 The DTS, which was developed in 1987 by Mark et al, 82 is the most widely used of all risk scores in exercise stress testing and has diagnostic and prognostic value in both women and men. The use of the DTS in the interpretation of exercise stress testing is recommended in the current ACC/AHA guidelines for exercise stress testing. 13 This score was originally developed with the use of data from 2842 patients, including 30% women, with known or possible CAD who underwent exer-cise testing before diagnostic angiography and had no prior revascularization or recent myocardial infarction. 82 The DTS incorporates exercise time (which is also a measure of exercise capacity), ST-segment depression, and the presence or absence of angina, as follows:
DTSϭexercise timeϪ͑5ϫST deviation͒
Ϫ͑4ϫangina score index͒ Exercise time is measured in minutes on the Bruce protocol. ST deviation is greatest net ST-segment deviation in any lead other than aVR, and the angina score index is scored from 0 to 2, where 0 is no angina, 1 is nonlimiting angina with exercise, and 2 is exercise-limiting angina. Recognized categories for the calculated DTS are low risk (DTS Նϩ5), moderate risk (DTS Ϫ10 to ϩ4), and high risk (DTS ՅϪ11). 84 
Diagnostic Value
The DTS has been shown to have diagnostic value in both women and men. 82,84 -86 The diagnostic value of the DTS was shown in a study of 2758 symptomatic patients (30% women) who underwent exercise stress testing with subsequent angiography. 86 Patients with a high-risk DTS were 376-fold more likely to have significant CAD than those with a low-risk DTS.
Similar results for the diagnostic value of DTS have also been demonstrated in symptomatic women. 85 In a series of 976 symptomatic women referred for exercise testing and coronary angiography, the presence of CAD correlated with category of DTS risk: 19.1% of low-risk DTS, 34.9% of moderate-risk DTS, and 89.2% of high-risk DTS had at least 1-vessel CAD with 75% stenosis. Although women had less coronary disease compared with their male counterparts at every level of DTS, the relationship between DTS and presence of CAD was similar. Eighty-one percent of low-risk DTS women had no coronary stenosis Ͼ75%, whereas 46% of women with a high-risk DTS had 3-vessel or left main disease. In symptomatic men, 52.6% with a low-risk DTS had no coronary stenosis, and 71.5% with a high-risk DTS had 3-vessel or left main disease.
Prognostic Value
The DTS has been shown to be an excellent prognostic tool in symptomatic women as well as men. A low-risk DTS is associated with a lower mortality rate. 82, 84, 85 In both genders, a low-risk DTS was associated with an annual mortality rate of Ϸ0.25%, in contrast with an annual mortality rate of 5% in those with a high-risk DTS. 84 The prognostic ability of the DTS has been confirmed in a number of studies that followed. 82, 84, 85 Overall, survival for women appears to be better at all levels of the DTS compared with men. 82, 85 The DTS is a valuable tool to predict the risk of future myocardial infarction, revascularization, cardiac survival, and all-cause mortality in both genders, but it does not appear effective at assessing prognosis in the elderly (those aged Ն75 years). 87 The prognostic value of the DTS has been demonstrated in asymptomatic women. In the Women Take Heart Project, the DTS was an independent predictor of all-cause and cardiac mortality in asymptomatic women. 43 Those women with a moderate-or high-risk DTS had a hazard ratio for all-cause mortality that was twice that of women with a low-risk DTS (PϽ0.001). The hazard ratio for cardiac death was 2.5 times greater in those with a high-risk DTS than those with a low-risk DTS (PϽ0.001). Because of the rare occurrence of symptoms and infrequency of ST-segment depression with exercise stress testing in asymptomatic women, the predictive value of the DTS was equal to that of exercise capacity in this cohort of women. 43 
Exercise Stress Testing With Imaging
The addition of imaging to exercise, with either SPECT or echocardiography, is recommended by the AHA Consensus Statement in the evaluation of intermediate-risk women who have an abnormal exercise ECG or an abnormal baseline ECG that would preclude the interpretation of ST-segment depression with exercise. 14 Both exercise stress echocardiography and SPECT techniques have limitations that are specific to women and must be taken into consideration. 88 In exercise SPECT imaging, a false-positive test result can occur because of soft tissue attenuation due to either breast tissue or body habitus. 89 -91 Other gender differences in exercise SPECT may be explained by reduced left ventricular cavity size and smaller coronary arteries in women. 90 Stress echocardiography may be limited by the variability in acoustic windows and the ability to capture images at the point of maximal stress. Despite these limitations, both the diagnostic accuracy and prognostic value of stress SPECT and stress echocardiography exceed those of exercise ECG alone, with no significant differences between men and women.
Diagnostic Value
Exercise stress echocardiography has a higher specificity and sensitivity than exercise ECG alone, increasing the specificity and sensitivity to 81% to 86% and 80% to 88%, respectively, for diagnosis of obstructive coronary disease in symptomatic women. 33, [92] [93] [94] These values are similar to the sensitivity and specificity of these tests in men. 95 In 161 symptomatic women undergoing exercise echocardiography and subsequent angiography, ST-segment depression with exercise and exercise-induced wall motion abnormalities had similar sensitivity, but the echocardiogram had a much higher specificity in the detection of coronary disease (80% for exercise echocardiography versus 56% for exercise ECG in this study). 92 The positive predictive value of exercise echocardiography in this same population was 74%, and the NPV was 86%.
Similar to exercise echocardiography, the diagnostic accuracy of exercise SPECT exceeds that of exercise ECG alone in women. 96, 97 In a study of symptomatic postmenopausal women undergoing exercise SPECT, the accuracy of exercise testing was improved by the addition of nuclear imaging. 97 The sensitivity and specificity of exercise ECG alone in this population were 67% and 69%, respectively, but with SPECT, the sensitivity and specificity rose to Ϸ88% for both. In the diagnosis of CAD in symptomatic women, the sensitivity of exercise SPECT ranges from 78% to 88%, with a specificity of 64% to 91%, [97] [98] [99] and there appear to be no significant differences in diagnostic accuracy between men and women. 98 -101 There has been no direct comparison of the diagnostic ability of exercise SPECT and exercise echocardiography. In a systematic review of the literature of exercise testing with imaging that included women, the results of 10 studies in which SPECT was used and 4 studies in which echocardiography was used were combined. There was no difference between exercise SPECT and exercise echocardiography in the sensitivity (77% and 81%, respectively) and specificity (63% and 73%, respectively) for the diagnosis of CAD in women. 102 
Prognostic Value
Exercise echocardiography and SPECT both provide incremental prognostic information in women beyond the exercise ECG when one relies on ST-segment depression alone. Women with no ECG or echocardiographic evidence of ischemia had an excellent (96%) cardiac event-free survival over Ͼ3 years of follow-up, in contrast to a much higher cardiac event rate in those women with ECG and echocardiographic findings consistent with ischemia (cardiac eventfree survival of 55%). 103 In the same study, women with positive ECG findings and negative echocardiographic findings with stress had a longer event-free survival than women with negative ECG findings but echocardiographic findings consistent with ischemia. 103 The prognostic value of exercise echocardiography appears to be similar in men and women. 55, 104 Similarly, exercise SPECT provides more prognostic value than ST-segment depression alone in women. In a study of men and women undergoing exercise SPECT, the imaging results provided 37% more prognostic information than exercise ECG variables, and, in fact, the SPECT imaging was better at predicting future cardiac events in women compared with men (area under the curve, 0.84 in women versus 0.71 in men; PϽ0.0005). 105 Although these imaging modalities have not been compared directly, it appears that exercise stress echocardiography and SPECT have similar prognostic value in the prediction of cardiac events and death in women. In a meta-analysis of exercise echocardiography and SPECT imaging by Metz et al, 106 both exercise imaging modalities had the same NPV in women (99% versus 98%, respectively), which was similar to our findings in men. The authors suggested that the use of either imaging modality was appropriate for either gender, and the choice of test should depend on the experience and cost at individual institutions.
Algorithm for Stress Testing in Women Asymptomatic Women
As described above, exercise stress testing appears to provide important prognostic information in asymptomatic women, beyond traditional risk factors. 39, 40 However, there are no studies to date demonstrating that an intervention to improve exercise parameters changes outcomes. 47 As such, although exercise stress testing information may better risk stratify women beyond traditional cardiac risk factor assessment, exercise stress testing in asymptomatic women for this purpose is not currently recommended. 13, 107 
Symptomatic Women
When a woman is evaluated for CAD, it is important to consider Bayes' theorem in identifying which women will benefit most from stress testing. 108 The pretest likelihood of CAD influences the posttest risk of CAD, and in a low-risk patient, a positive stress test result may be more likely to represent a false-positive result, leading to additional invasive, and often unnecessary, testing. Exercise testing is not recommended in this group. 14 In intermediate-risk patients, exercise testing will identify a subgroup of women who are more likely to have CAD. Determining the pretest probability of CAD in women includes an assessment of cardiac risk factors as well as the patient's symptoms. From the ACC/AHA Guidelines for Exercise Testing, an intermediaterisk woman is either older than 50 years with typical or atypical angina or is younger than 50 years with typical angina (Table  1) . 13 Symptomatic women who have diabetes mellitus or multiple cardiac risk factors should also be considered for stress testing. 14 There is a wide range of stress testing modalities available for diagnosing CAD in symptomatic women. Table 2 provides a summary of the diagnostic value of these modalities in the detection of CAD. On the basis of the current literature, the following algorithm for stress testing in women is proposed (Figure 2) .
The exercise ECG is the recommended first test of choice in the evaluation of symptomatic, intermediate-risk women who are able to exercise and have a normal baseline ECG. Given the strong diagnostic and prognostic information that can be determined with exercise variables, any woman who is able to exercise should preferentially undergo this method of testing over pharmacological testing. To determine which women will perform adequately on an exercise stress ECG, the Duke Activity Status Index questionnaire can be used for screening. The Duke Activity Status Index questionnaire is a 
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self-administered 12-question form designed to provide an assessment of exercise capacity, and an estimated exercise capacity of Ͻ5 METs may be a reason to undergo a pharmacological stress test rather than an exercise stress test, given that such a low exercise capacity may not adequately induce ischemia. 109, 110 The diagnostic and prognostic accuracy of exercise testing in women can be improved by incorporating parameters such as exercise capacity, chronotropic response, HRR, blood pressure response, and the DTS, in addition to ST-segment depression with exercise (Table 3) . 111 A negative stress ECG has a high NPV, which in combination with its low cost and wide availability make it the recommended first step in the evaluation of a symptomatic woman with chest pain. A positive or inconclusive exercise ECG should be followed by stress testing with imaging or angiography if the exercise ECG appears particularly high risk. Similar to the stress ECG alone, negative stress testing with imaging effectively rules out CAD in a symptomatic woman.
Conclusion
The standard exercise stress test is recommended by the AHA, the ACC, and the American Society of Nuclear Cardiology as the initial stress test of choice in most patients who can exercise, including women. 13, 14 Use of the exercise stress test with imaging is recommended when an ECG cannot be interpreted (with the noted exception of women with a left bundle branch block, who will require a pharmacological stress test), if a patient is on digoxin, or if the exercise stress test is abnormal. 13 Nonetheless, exercise stress testing with imaging or pharmacological testing is often the immediate choice for many physicians without regard for the recommendation of the guidelines and without regard for the important diagnostic and prognostic information that can be retrieved from the exercise ECG. 52, 112, 113 In the current climate of rising healthcare costs, it is important to critically evaluate the manner in which to appropriately use exercise stress testing in women to make accurate diagnostic assessments, reduce radiation exposure, and ensure appropriate allocation of medical resources. Although the focus of stress exercise ECG has centered mainly on ST-segment depression as a method of diagnosing CAD, the use of additional exercise parameters in women improves the diagnostic accuracy of the exercise stress test, as well as the prognostic assessment. In women, exercise capacity, percentage of age-predicted exercise capacity, chronotropic response, HRR, blood pressure response, and the DTS can all be used to enhance the diagnostic and prognostic value of exercise ECG. Standardization of exercise stress test reporting should include this information, in addition to information regarding ST-segment depression. An assessment of risk stratification should be described in the report in such a way that the ordering physician may make use of this information. By providing the important diagnostic and prognostic data, physicians may adequately assess their patients' risk to aid in referral for further testing or management of cardiac risk factors.
By following the guidelines and appropriately using the exercise stress test, as outlined here and as recommended by the exercise testing guidelines, significant cost savings may be achieved. 52 Diagnostic imaging should be used when appropriate but is not required in all women simply on the basis of fear of a possible false-positive stress test. Diagnostic imaging has been the fastest growing cost for Medicare and has been targeted for appropriateness of use by the Office of the Inspector General. 113, 114 The exercise ECG has an excellent NPV, and it should continue to serve as a method for distinguishing those women who do not require any further testing from those women who would benefit from further exercise stress testing with imaging. Although imaging can add to the diagnostic accuracy of exercise stress testing in women, these tests have significant additional costs associated with them and should only be used when appropriate. 115, 116 A woman who has no ST-segment depression, excellent functional capacity, and low-risk DTS is unlikely to have CAD, 52 and no further is testing is required.
By going back to the basics of exercise testing and using all of the important information that comes with any exercise stress test, we can improve the diagnostic and prognostic value of the exercise stress test and adequately risk stratify women, and we can provide a customized approach to the diagnosis and prognosis of CAD in women.
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